Answers are grounded in this paper and cite their sources.
Invasive pulmonary fungal infection (IPFI) is increasingly recognized among patients with community-acquired pneumonia (CAP) who lack classic host factors associated with immunosuppression. This study aimed to determine the proportion of clinically identified IPFI and evaluate its independent risk factors, with particular emphasis on respiratory viral polymerase chain reaction (PCR) positivity at admission. We conducted a retrospective cohort study at National Lung Hospital in Hanoi, Vietnam, from December 2024 to July 2025. Adult patients with CAP who were hospitalized in general wards and underwent multiplex respiratory polymerase chain reaction testing for 16 respiratory bacterial and viral pathogens were enrolled. Patients with immunocompromised conditions, intensive care unit (ICU) admission, or symptom duration of more than 21 days were excluded. IPFI was diagnosed using adapted 2019 European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) criteria. Independent determinants of IPFI were identified using penalized selection followed by multivariable Firth’s logistic regression analysis. The study included 188 patients with a median age of 66 years, of whom 76% were male. IPFI was diagnosed in 24 patients (12.8%), including 23 cases of aspergillosis and one case of mucormycosis. In-hospital mortality was significantly higher among patients with IPFI than among those without IPFI (33.3% vs. 2.4%, P < 0.001). Multivariable analysis showed that respiratory viral PCR positivity (adjusted odds ratio [aOR] 3.15; 95% CI 1.26–8.18; P = 0.014), diabetes mellitus (aOR 4.10; 95% CI 1.45–11.55; P = 0.008), and peribronchial infiltration on chest computed tomography (aOR 4.70; 95% CI 1.87–12.48; P < 0.001) were independently associated with IPFI. IPFI is a clinically relevant complication among non-ICU adult patients hospitalized with CAP who lack classic immunosuppressive conditions and is associated with substantially higher in-hospital mortality. Increased clinical vigilance and early fungal diagnostic evaluation should be considered in this population, particularly among patients with positive respiratory viral PCR at admission and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Dinh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: